pubmed-article:21677588 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21677588 | lifeskim:mentions | umls-concept:C0201811 | lld:lifeskim |
pubmed-article:21677588 | lifeskim:mentions | umls-concept:C1721048 | lld:lifeskim |
pubmed-article:21677588 | lifeskim:mentions | umls-concept:C0871311 | lld:lifeskim |
pubmed-article:21677588 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
pubmed-article:21677588 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
pubmed-article:21677588 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:21677588 | pubmed:dateCreated | 2011-7-7 | lld:pubmed |
pubmed-article:21677588 | pubmed:abstractText | The primary aim was to assess the value of immunochemical and guaiac fecal occult blood test (FOBT) as a screening test before capsule endoscopy (CE) in the setting of obscure gastrointestinal bleeding (OGIB). | lld:pubmed |
pubmed-article:21677588 | pubmed:language | eng | lld:pubmed |
pubmed-article:21677588 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21677588 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21677588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21677588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21677588 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21677588 | pubmed:month | Aug | lld:pubmed |
pubmed-article:21677588 | pubmed:issn | 1473-5687 | lld:pubmed |
pubmed-article:21677588 | pubmed:author | pubmed-author:TaylorAndrew... | lld:pubmed |
pubmed-article:21677588 | pubmed:author | pubmed-author:AllenPatrick... | lld:pubmed |
pubmed-article:21677588 | pubmed:author | pubmed-author:EfthymiouMari... | lld:pubmed |
pubmed-article:21677588 | pubmed:author | pubmed-author:JayasekeraCha... | lld:pubmed |
pubmed-article:21677588 | pubmed:author | pubmed-author:TaylorPaul... | lld:pubmed |
pubmed-article:21677588 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21677588 | pubmed:volume | 23 | lld:pubmed |
pubmed-article:21677588 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21677588 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21677588 | pubmed:pagination | 690-4 | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:meshHeading | pubmed-meshheading:21677588... | lld:pubmed |
pubmed-article:21677588 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21677588 | pubmed:articleTitle | Value of fecal occult blood test as a screening test before capsule endoscopy. | lld:pubmed |
pubmed-article:21677588 | pubmed:affiliation | Department of Gastroenterology, St Vincent's Hospital, Melbourne, Australia. mariosefthymiou@hotmail.com | lld:pubmed |
pubmed-article:21677588 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21677588 | pubmed:publicationType | Evaluation Studies | lld:pubmed |